The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127271321 12727132 1 I 20160721 20160909 20160909 EXP GB-ALEXION PHARMACEUTICALS INC.-A201605473 ALEXION 0.00 F Y 0.00000 20160909 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127271321 12727132 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, QW 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
127271321 12727132 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W P0005002 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
127271321 12727132 3 SS SOLIRIS ECULIZUMAB 1 900 MG, Q2W P0005002 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
127271321 12727132 4 C FOLIC ACID. FOLIC ACID 1 Oral UNK 0
127271321 12727132 5 C VITAMIN B12 CYANOCOBALAMIN 1 Oral UNK 0
127271321 12727132 6 C IRON IRON 1 Oral UNK 0
127271321 12727132 7 C MAGNESIUM MAGNESIUM 1 Oral UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127271321 12727132 1 Paroxysmal nocturnal haemoglobinuria
127271321 12727132 4 Product used for unknown indication
127271321 12727132 5 Product used for unknown indication
127271321 12727132 6 Product used for unknown indication
127271321 12727132 7 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127271321 12727132 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127271321 12727132 Abortion spontaneous
127271321 12727132 Chest discomfort
127271321 12727132 Exposure during pregnancy
127271321 12727132 Fatigue
127271321 12727132 Muscle strain
127271321 12727132 Thirst

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127271321 12727132 1 20130821 20130912 0
127271321 12727132 2 20130919 0